StockData

Addus HomeCare vs Aveanna Healthcare

ADUS and AVAH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADUS and AVAH compare

Addus HomeCare and Aveanna Healthcare are about the same size, with market caps of $2.3B and $2.5B.

On earnings, Aveanna Healthcare is cheaper: it trades at 9.5× trailing earnings, against 21.3× for Addus HomeCare.

Aveanna Healthcare grew revenue faster over the last twelve months (19.5% versus 15.9% for Addus HomeCare).

Aveanna Healthcare keeps more of each dollar of sales as profit, with a net margin of 10.6% compared with 7.1% at Addus HomeCare.

Addus HomeCare scores higher on the StockData Score (20 against 12 for Aveanna Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADUSAVAH
Size and price
Market cap$2.3B$2.5B
Share price$121.56$11.65
Change, 1 year11.5%37.9%
Change, 5 years33.0%63.2%
Beta (5Y)0.280.35
Employees5,29032K
StockData Score
Total score20 (better)12
Valuation score5 (better)4
Growth score4 (better)3
Performance score5 (better)4
Health score6 (better)1
Dividend score00
Valuation
P/E21.3×9.5× (better)
P/S1.5×1.0× (better)
P/B2.0× (better)8.8×
EV/EBITDA13.5×13.1× (better)
P/FCF14.7×–
PEG0.95–
FCF yield6.8%–
Fair value$137.11$22.33
Margin of safety11.3%47.8% (better)
Growth
Revenue growth (TTM)15.9%19.5% (better)
Revenue growth, 5Y average13.2% (better)10.2%
Net income growth (TTM)26.9%1381% (better)
EPS growth (TTM)25.8%1267% (better)
EPS growth, 5Y average20.2%–
Profitability
Gross margin32.4% (better)32.3%
Operating margin10.0%10.5% (better)
Net margin7.1%10.6% (better)
FCF margin10.5%–
Return on equity9.7%200% (better)
Return on invested capital10.0%20.6% (better)
Financial health
Debt / equity0.05 (better)4.52
Net debt / EBITDA−0.234.21 (better)
Interest coverage14.9× (better)2.2×
Current ratio1.69 (better)1.16
Altman Z-score6.37 (better)1.83
Piotroski F-score67 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions104%93.0%
Held by insiders2.8%33.2%
Insider net buying, 12 months−$20.7M (better)−$782M
Short interest, % of float5.5%5.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.